Page last updated: 2024-10-26

etidronate and Lung Diseases, Interstitial

etidronate has been researched along with Lung Diseases, Interstitial in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jankovic, S1
Pavlov, N1
Ivkosic, A1
Erceg, I1
Glavina-Durdov, M1
Tocilj, J1
Dragisic-Ivulic, S1
Primorac, D1

Other Studies

1 other study available for etidronate and Lung Diseases, Interstitial

ArticleYear
Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up.
    Pediatric pulmonology, 2002, Volume: 34, Issue:5

    Topics: Child; Etidronic Acid; Female; Humans; Lithiasis; Lung Diseases, Interstitial; Tomography, X-Ray Com

2002